Nirsevimab for the prevention of respiratory syncytial virus disease in children. Statement of the Spanish Society of Paediatric Infectious Disease (SEIP) Laura Francisco; Marta Cruz-Cañete; Carlos Pérez; José Antonio Couceiro; Enrique Otheo; Cristian Launes; Carlos Rodrigo; Ana Belén Jiménez; Marta Llorente; Abián Montesdeoca; José Rumbao; Cristina Calvo; Susana Frago; Alfredo Tagarro;

COVID-19 admissions: Trying to define the real impact of infection in hospitalized patients Claudia Solito; María Hernández-García; Noelia Arguedas Casamayor; Alba Pavón Ortiz; Rosa Pino; Laia Alsina; Mariona F. de Sevilla;

Clinical characteristics and mortality risk factors in patients aged less than 18 years with COVID-19 in Mexico and Mexico City Rosa María Wong-Chew; Daniel Ernesto Noyola; Antonio Rafael Villa;